<?xml version="1.0" encoding="utf-8"?>
<oembed>
  <version>1</version>
  <type>rich</type>
  <provider_name>Libsyn</provider_name>
  <provider_url>https://www.libsyn.com</provider_url>
  <height>90</height>
  <width>600</width>
  <title>Episode 437: Remembering David Mitchell</title>
  <description>    I don't have to remind anyone who listens to this podcast that the cost of MS disease-modifying therapies is obscenely high. And we're not just talking about relatively new medications. Older medications -- some decades old -- continue to increase in price without any rational explanation for why or how. &amp;amp;nbsp; On January 2nd, we lost a true warrior in the ongoing battle to lower the price of prescription drugs when David Mitchell, the founder of Patients for Affordable Drugs, passed away. &amp;amp;nbsp;      I met David in 2018 at a National MS Society Public Policy Conference, and he was a guest on Episode 31 of RealTalk MS. &amp;amp;nbsp;This week, I'm re-sharing the conversation we had in 2018. We'll also tell you about an international workshop that represents the initial steps in developing a global research agenda to end MS. We're explaining how AI is about to have a major impact on healthcare. And we'll share the American Medical Association's brief to Congress, making the case for extending access to telehealth. We have a lot to talk about! Are you ready for RealTalk MS??!   This Week: We're remembering David Mitchell&amp;amp;nbsp; :22 The first steps toward a global research agenda to prevent MS were just published&amp;amp;nbsp; 1:02 Doctor AI will see you now&amp;amp;nbsp; 5:45 The American Medical Association asks lawmakers to extend access to telehealth&amp;amp;nbsp; 10:27 David Mitchell in his own words&amp;amp;nbsp; 12:41 Share this episode&amp;amp;nbsp; 27:56 Next week&amp;amp;nbsp; 28:16   SHARE THIS EPISODE OF REALTALK MS Just copy this link &amp;amp;amp; paste it into your text or email: https://realtalkms.com/437 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is&amp;amp;nbsp;your&amp;amp;nbsp;opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the&amp;amp;nbsp;RealTalk MS Listener Hotline&amp;amp;nbsp;and share your thoughts! Email:&amp;amp;nbsp;jon@realtalkms.com Phone:&amp;amp;nbsp;(310) 526-2283 And don't forget to join us in the&amp;amp;nbsp;RealTalk MS Facebook group!   LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the&amp;amp;nbsp;RealTalk MS app&amp;amp;nbsp;or at&amp;amp;nbsp;www.RealTalkMS.com Patients for Affordable Drugs https://patientsforaffordabledrugs.org  PAPER: Toward a Global Research Agenda for Preventing Multiple Sclerosis https://journals.sagepub.com/doi/10.1177/13524585251398381  AMA BRIEF: The Case for Permanent Telehealth Policy and Expanded Access to Virtual Care https://ama-assn.org/system/files/issue-brief-telehealth-policy-expanded-access-to-virtual-care.pdf  ChatGPT Health https://openai.com/index/introducing-chatgpt-health  JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review   Follow RealTalk MS on Twitter,&amp;amp;nbsp;@RealTalkMS_jon, and subscribe to our newsletter at our website,&amp;amp;nbsp;RealTalkMS.com. RealTalk MS Episode 437 Guests: David Mitchell  Privacy Policy       </description>
  <author_name>RealTalk MS</author_name>
  <author_url>http://www.realtalkms.com</author_url>
  <html>&lt;iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39690200/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen&gt;&lt;/iframe&gt;</html>
  <thumbnail_url>https://assets.libsyn.com/secure/content/197368815</thumbnail_url>
</oembed>
